SCHEMBL2783166

SCHEMBL2783166

Nc1ccc2cc3c(C(O)(C(F)(F)F)C(F)(F)F)c(N)ccc3cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP3A4 P08684 2/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
HBB P68871 1/20 0.42
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
GLA P06280 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
ATM Q13315 1/20 0.36
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2784369 1.00 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP3A4ALOX15CASP1
SCHEMBL2783950 0.92 SMN1; SMN2 (0.42) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL2783869 0.92 SMN1; SMN2 (0.42) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL2784728 0.92 SMN1; SMN2 (0.42) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL2784101 0.89 SMN1; SMN2 (0.40) ALDH1A1HSD17B10CYP3A4ALOX15CASP1
SCHEMBL2784474 0.89 SMN1; SMN2 (0.44) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL2784132 0.87 MEN1 (0.42) ALDH1A1HSD17B10CYP3A4ALOX15CASP1
SCHEMBL2786121 0.87 SMN1; SMN2 (0.43) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL2785773 0.86 SMN1; SMN2 (0.38) ALDH1A1HSD17B10CYP3A4ALOX15CASP1
SCHEMBL2784478 0.86 SMN1; SMN2 (0.40) ALDH1A1HSD17B10SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 US disclosed
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom AFF2, AFF1, AFF4 ALDH1A1 931/4885HSD17B10 3598/4885CYP3A4 3797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.